SLDB
Solid Biosciences LLC
8.50$
-4.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.7% | +50.8% | -7.1% | -8.3% | -10.9% | +82.3% | -10.4% | -11.2% | -15.1% | +81.9% | -0.5% | |
| – | -12.5% | +65.1% | -7.7% | -9.2% | -12.4% | +99.2% | -11.1% | -12.1% | -16.1% | +93.1% | -0.4% | |
| – | +50.9% | +58.9% | -18.5% | -32.8% | +24.6% | +162.5% | -34.0% | -55.8% | -2.4% | +397.1% | -46.5% | |
| – | -13.5% | +66.7% | -7.7% | -10.1% | -13.0% | +106.1% | -12.6% | -11.9% | -20.5% | +103.0% | -1.0% | |
| – | -4.7% | -1.3% | -0.6% | +18.7% | +14.8% | -3.8% | +1.1% | +11.9% | -6.1% | -7.2% | -4.6% | |
| – | -8.2% | -1.2% | +2.4% | +55.6% | +32.4% | -4.9% | +3.7% | +21.8% | -7.9% | -9.5% | -5.6% | |
| – | +1.5% | -5.8% | +2.7% | +23.1% | +9.0% | -1.8% | -2.3% | -20.1% | -9.1% | +4.0% | +2.1% | |
| – | +7.1% | -14.9% | +45.7% | +37.2% | +22.5% | +52.0% | -26.9% | +79.2% | -61.8% | +72.5% | -21.6% | |
| – | -12.4% | +66.6% | -8.3% | -13.6% | -17.8% | +114.6% | -12.3% | -15.6% | -17.4% | +107.8% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +44.7% | +31.5% | +7.3% | +1.2% | +29.3% | +23.8% | +41.9% | +0.3% | +0.3% | +15.9% | +30.9% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.